Abstract
BackgroundThe Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) is the core determinant of response in the SLE Responder Index (SRI), a primary efficacy outcome in SLE clinical trials. However, SLEDAI...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have